Fox Chase Cancer Center Welcomes Andrea S. Porpiglia

June 15, 2020

Porpiglia will begin July 1, 2020, seeing patients at Fox Chase main campus and Fox Chase East Norriton.Porpiglia will begin July 1, 2020, seeing patients at Fox Chase main campus and Fox Chase East Norriton.PHILADELPHIA (June 15, 2020) – Fox Chase Cancer Center announces the hiring of Andrea S. Porpiglia, MD, MSc, who will join the Department of Surgical Oncology in the Division of General Surgery. Porpiglia will be an assistant professor in the academic clinician track.

Porpiglia, who was a Complex Surgical Oncology Fellow at Fox Chase, is returning to the center after serving as division chief of surgical oncology in the department of surgery at
Crozer-Keystone Health System.

She received her medical degree from the University of Tennessee Health Science Center in Memphis and stayed on to complete her residency in general surgery. She was a research technologist in the department of immunology at St. Jude Children’s Research Hospital in Memphis, Tennessee, before becoming their senior research technologist.

Porpiglia is certified by the American Board of Surgery in complex general surgical oncology and general surgery.

She is a member of the Society of Surgical Oncology, Pennsylvania Medical Society, American Society of Clinical Oncology, American College of Surgeons, and the Association of Women Surgeons.

Porpiglia serves on the Association of Women Surgeons conference planning committee, the Society of Surgical Oncology CME committee. She served as an LLC board member of the Prospect Provider Group in Pennsylvania and on the Oncology Strategic Leadership Committee.

She has been published in several peer-reviewed journals, presented at multiple annual meetings/symposiums, and has guest lectured.

Porpiglia will begin work at Fox Chase on July 1, 2020. She will see patients at Fox Chase main campus and Fox Chase East Norriton.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase